Avastin challenges Lucentis dominance in wet AMD

Avastin challenges Lucentis dominance in wet AMD

Posted on 26th April 2012

The leading wet AMD treatment used in the NHS, Lucentis, is under pressure from a cheaper version called Avastin.

Both compounds are from the family of AntiVEGF drugs (anti-vascular endothelial growth factor). In wet AMD, the degeneration causes the retina to make tiny new blood vessels in response to damage. These blood vessels are very fragile and break and bleed into the retina causing scarring and eventually vision loss.

AntiVEGF drugs stop and even shrink the growth of these new blood vessels preventing the damaging bleeding. Until now Lucentis has been the only approved drug for use in the eye and costs over £700 per injection (used in multiples of 3 injections normally). Avastin is in the same family of drugs and currently used to treat heart conditions. Costing only £60 per injection, many specialists in other countries have been using it ‘off label’ in the eye to great effect.

Avastin is now being used to treat 50% of AMD cases in the US and there is increasing pressure on the NHS to approve the use of this drug enabling far more access to the sight saving treatment.

At Cameron Optometry, we’re experts in all forms of macular disease and have the latest OCT technology which is used by specialists to diagnose and monitor the effects of treatment on wet AMD. If you are concerned or have a family history of the condition, come and see us for some expert advice.


Related Posts

Cameron Optometry first practice to welcome most advanced scanner available worldwide

22nd February 2018

This week, we welcome the Optos California scanner to the practice, continuing our commitment to ensure we always have the latest technology available. We are the first optometry practice in Scotland ...

Read more

Cameron Optometry shortlisted for two Optician Awards

15th February 2018

We are thrilled to announce that we have been shortlisted for two categories in the highly regarded national UK Optician Awards. Recognised as the benchmark of excellence in the optical community, the...

Read more

Specialist support for children adapting to contact lens wear

29th January 2018

Heather Muir has completed further training to ensure Cameron Optometry continues to provide highest level of care to young patients, in particular those transitioning to contact lens wear. Last y...

Read more

Myopia Management: Gillian Bruce shares expertise

25th January 2018

Our clinical lead optometrist, Gillian Bruce, is regularly called upon to share her expertise in Myopia Management, reducing the progression of short-sightedness in children, in the UK and further afi...

Read more